Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Study Administering Rapamycin (Sirolimus) With Ketoconazole in Patients With Advanced Malignancies

NCT00708591 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00708591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00708591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Study Administering Rapamycin (Sirolimus) With Ketoconazole in Patients With Advanced Malignancies
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2004
Completion date
December 31, 2008
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer